Attenuation of nonsense-mediated mRNA decay facilitates the response to chemotherapeutics

Area of Science:

• Molecular Biology
• Cell Biology
• Genetics

Background:

• Nonsense-mediated mRNA decay (NMD) is a crucial cellular surveillance pathway that degrades aberrant mRNAs with premature termination codons.
• NMD also regulates the expression levels of numerous endogenous transcripts, impacting cellular homeostasis.
• The key NMD factor UPF1 plays a central role in this process.

Purpose of the Study:

• To investigate the impact of chemotherapeutic compounds on NMD activity in human cells.
• To elucidate the mechanism by which NMD activity is modulated by chemotherapy.
• To explore the therapeutic potential of targeting NMD in cancer treatment.

Main Methods:

• Treatment of human cells with clinically used chemotherapeutic agents.
• Analysis of UPF1 protein levels and cleavage products.
• Assessment of NMD activity using reporter assays and endogenous transcript analysis.
• Pharmacological inhibition of NMD using NMDI-1.
• Genetic manipulation to inhibit UPF1 cleavage.

Main Results:

• Chemotherapeutic treatment leads to a decline in NMD activity.
• This decline is mediated by the proteolytic production of a dominant-interfering, cleaved form of UPF1.
• Cleaved UPF1 upregulates genes involved in apoptotic stress response, promoting cell death.
• Combined treatment with an NMD inhibitor (NMDI-1) and doxorubicin enhances cell death.
• Inhibition of UPF1 cleavage confers protection against doxorubicin-induced cell death.

Conclusions:

• Chemotherapy disrupts NMD by inducing UPF1 cleavage, thereby promoting apoptosis.
• Targeting UPF1 cleavage or NMD activity represents a potential strategy to enhance the efficacy of chemotherapy.
• This study provides a mechanistic link between NMD regulation and chemotherapy-induced cell death.